Idris Guessous

InstitutionUniversity of Lausanne
AddressLausanne
Switzerland
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 28 Covid-19 publications, with a maximum of 4 publications in June 2021
    All Publications
    Bar chart showing 190 publications over 18 distinct years, with a maximum of 23 publications in 2015
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. De Ridder D, Loizeau AJ, Sandoval JL, Ehrler F, Perrier M, Ritch A, Violot G, Santolini M, Greshake Tzovaras B, Stringhini S, Kaiser L, Pradeau JF, Joost S, Guessous I. Detection of Spatiotemporal Clusters of COVID-19-Associated Symptoms and Prevention Using a Participatory Surveillance App: Protocol for the @choum Study. JMIR Res Protoc. 2021 Oct 06; 10(10):e30444. PMID: 34449403.
      Citations:    
    2. Pagano S, Yerly S, Meyer B, Juillard C, Suh N, Le Terrier C, Daguer JP, Farrera-Soler L, Barluenga S, Piumatti G, Hartley O, Lemaitre B, Eberhardt CS, Siegrist CA, Eckerle I, Stringhini S, Guessous I, Kaiser L, Pugin J, Winssinger N, Vuilleumier N. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1. Eur J Clin Invest. 2021 Nov; 51(11):e13661. PMID: 34324704.
      Citations:    Fields:    Translation:Humans
    3. Spechbach H, Jacquerioz F, Prendki V, Kaiser L, Smit M, Calmy A, Chappuis F, Guessous I, Salamun J, Baggio S. Network Analysis of Outpatients to Identify Predictive Symptoms and Combinations of Symptoms Associated With Positive/Negative SARS-CoV-2 Nasopharyngeal Swabs. Front Med (Lausanne). 2021; 8:685124. PMID: 34355004.
      Citations:    
    4. Perez-Saez J, Zaballa ME, Yerly S, Andrey DO, Meyer B, Eckerle I, Balavoine JF, Chappuis F, Pittet D, Trono D, Kherad O, Vuilleumier N, Kaiser L, Guessous I, Stringhini S, Azman AS. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clin Microbiol Infect. 2021 Nov; 27(11):1695.e7-1695.e12. PMID: 34245905.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    5. Nehme M, Braillard O, Chappuis F, Courvoisier DS, Guessous I. Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting. Ann Intern Med. 2021 09; 174(9):1252-1260. PMID: 34224254.
      Citations: 4     Fields:    Translation:Humans
    6. Baggio S, Vernaz N, Spechbach H, Salamun J, Jacquerioz F, Stringhini S, Jackson Y, Guessous I, Chappuis F, Wolff H, Gétaz L. Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic. Prev Med. 2021 09; 150:106696. PMID: 34174252.
      Citations:    Fields:    Translation:HumansPHPublic Health
    7. Jacquerioz F, Baggio S, Gayet-Ageron A, Chappuis F, Getaz L, Guessous I, Kaiser L, Vernaz N, Yerly S, Salamun J, Spechbach H. Development and validation of the OUTCoV score to predict the risk of hospitalisation among patients with SARS-CoV-2 infection in ambulatory settings: a prospective cohort study. BMJ Open. 2021 06 18; 11(6):e044242. PMID: 34145007.
      Citations: 1     Fields:    Translation:Humans
    8. Bi Q, Lessler J, Eckerle I, Lauer SA, Kaiser L, Vuilleumier N, Cummings DAT, Flahault A, Petrovic D, Guessous I, Stringhini S, Azman AS. Insights into household transmission of SARS-CoV-2 from a population-based serological survey. Nat Commun. 2021 06 15; 12(1):3643. PMID: 34131124.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    9. Stringhini S, Zaballa ME, Pullen N, de Mestral C, Perez-Saez J, Dumont R, Picazio A, Pennacchio F, Dibner Y, Yerly S, Baysson H, Vuilleumier N, Balavoine JF, Bachmann D, Trono D, Pittet D, Chappuis F, Kherad O, Kaiser L, Azman AS, Guessous I. Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland. Nat Commun. 2021 06 08; 12(1):3455. PMID: 34103517.
      Citations: 2     Fields:    Translation:Humans
    10. Leidi A, Koegler F, Dumont R, Dubos R, Zaballa ME, Piumatti G, Coen M, Berner A, Darbellay Farhoumand P, Vetter P, Vuilleumier N, Kaiser L, Courvoisier D, Azman AS, Guessous I, Stringhini S. Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study. Clin Infect Dis. 2021 May 27. PMID: 34043763.
      Citations: 12     Fields:    
    11. Ladoy A, Opota O, Carron PN, Guessous I, Vuilleumier S, Joost S, Greub G. Size and duration of COVID-19 clusters go along with a high SARS-CoV-2 viral load: A spatio-temporal investigation in Vaud state, Switzerland. Sci Total Environ. 2021 Sep 15; 787:147483. PMID: 34000545.
      Citations: 4     Fields:    Translation:Humans
    12. Baggio S, Spechbach H, Vernaz N, Guessous I, Gétaz L, Kaiser L, Chappuis F, Salamun J, Jacquerioz F. SARS-CoV-2 testing strategy: A comparison of restricted and extended strategies in a Swiss outpatient cohort from the community and hospital employees. PLoS One. 2021; 16(4):e0250021. PMID: 33886627.
      Citations:    Fields:    Translation:Humans
    13. Andrey DO, Yerly S, Meyer B, Arm-Vernez I, Roux-Lombard P, Togni G, Guessous I, Spechbach H, Stringhini S, Agoritsas T, Stirnemann J, Reny JL, Siegrist CA, Eckerle I, Kaiser L, Vuilleumier N. Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence Settings. J Clin Med. 2021 Apr 10; 10(8). PMID: 33920076.
      Citations:    
    14. Chevallier Lugon C, Smit M, Salamun J, Abderrahmane M, Braillard O, Nehme M, Jacquerioz Bausch F, Guessous I, Spechbach H. Novel outpatient management of mild to moderate COVID-19 spares hospital capacity and safeguards patient outcome: The Geneva PneumoCoV-Ambu study. PLoS One. 2021; 16(3):e0247774. PMID: 33662012.
      Citations: 1     Fields:    Translation:Humans
    15. Stringhini S, Zaballa ME, Perez-Saez J, Pullen N, de Mestral C, Picazio A, Pennacchio F, Wisniak A, Richard A, Baysson H, Loizeau A, Balavoine JF, Trono D, Pittet D, Posfay-Barbe K, Flahault A, Chappuis F, Kherad O, Vuilleumier N, Kaiser L, Azman AS, Guessous I. Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak. Lancet Infect Dis. 2021 05; 21(5):600-601. PMID: 33539733.
      Citations: 12     Fields:    Translation:Humans
    16. De Ridder D, Sandoval J, Vuilleumier N, Azman AS, Stringhini S, Kaiser L, Joost S, Guessous I. Socioeconomically Disadvantaged Neighborhoods Face Increased Persistence of SARS-CoV-2 Clusters. Front Public Health. 2020; 8:626090. PMID: 33614571.
      Citations: 7     Translation:Humans
    17. Nehme M, Braillard O, Alcoba G, Aebischer Perone S, Courvoisier D, Chappuis F, Guessous I. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Ann Intern Med. 2021 05; 174(5):723-725. PMID: 33284676.
      Citations: 24     Fields:    Translation:HumansPHPublic Health
    18. Nehme M, Stringhini S, Guessous I. Perceptions of immunity and vaccination certificates among the general population: a nested study within a serosurvey of anti-SARS-CoV-2 antibodies (SEROCoV-POP). Swiss Med Wkly. 2020 11 16; 150:w20398. PMID: 33202421.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    19. Smit M, Marinosci A, Nicoletti GJ, Perneger T, Ragozzino S, Andrey DO, Stoeckle M, Jacquerioz F, Lebowitz D, Agoritsas T, Meyer B, Spechbach H, Salamun J, Back M, Schaubhut C, Fuchs S, Decosterd L, Battegay M, Guessous I, Chappuis F, Kaiser L, Labhardt ND, Calmy A. Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial. BMJ Open. 2020 11 12; 10(11):e040110. PMID: 33184083.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    20. West EA, Anker D, Amati R, Richard A, Wisniak A, Butty A, Albanese E, Bochud M, Chiolero A, Crivelli L, Cullati S, d'Acremont V, Epure AM, Fehr J, Flahault A, Fornerod L, Frank I, Frei A, Michel G, Gonseth S, Guessous I, Imboden M, Kahlert CR, Kaufmann L, Kohler P, Mösli N, Paris D, Probst-Hensch N, Rodondi N, Stringhini S, Vermes T, Vollrath F, Puhan MA. Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland. Int J Public Health. 2020 Dec; 65(9):1529-1548. PMID: 33098441.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    21. Mazouri-Karker S, Percheron Vendeuvre L, Sandoval J, Regard S, Braillard O, Guessous I, Nehme M. [Telemedicine at the heart of management of the COVID-19 crisis]. Rev Med Suisse. 2020 Sep 16; 16(706):1699-1702. PMID: 32936553.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    22. Andrey DO, Cohen P, Meyer B, Torriani G, Yerly S, Mazza L, Calame A, Arm-Vernez I, Guessous I, Stringhini S, Roux-Lombard P, Fontao L, Agoritsas T, Stirnemann J, Reny JL, Siegrist CA, Eckerle I, Kaiser L, Vuilleumier N. Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test. Eur J Clin Invest. 2020 Oct; 50(10):e13357. PMID: 32691863.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    23. Andrey DO, Cohen P, Meyer B, Torriani G, Yerly S, Mazza L, Calame A, Arm-Vernez I, Guessous I, Stringhini S, Roux-Lombard P, Fontao L, Agoritsas T, Stirnemann J, Reny JL, Siegrist CA, Eckerle I, Kaiser L, Vuilleumier N. Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests. J Clin Med. 2020 Jul 24; 9(8). PMID: 32722191.
      Citations: 13     
    24. Perez-Saez J, Lauer SA, Kaiser L, Regard S, Delaporte E, Guessous I, Stringhini S, Azman AS. Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect Dis. 2021 04; 21(4):e69-e70. PMID: 32679085.
      Citations: 57     Fields:    Translation:HumansPHPublic Health
    25. Meyer B, Torriani G, Yerly S, Mazza L, Calame A, Arm-Vernez I, Zimmer G, Agoritsas T, Stirnemann J, Spechbach H, Guessous I, Stringhini S, Pugin J, Roux-Lombard P, Fontao L, Siegrist CA, Eckerle I, Vuilleumier N, Vuilleumier N, Kaiser L. Validation of a commercially available SARS-CoV-2 serological immunoassay. Clin Microbiol Infect. 2020 Oct; 26(10):1386-1394. PMID: 32603801.
      Citations: 64     Fields:    Translation:HumansCellsPHPublic Health
    26. De Ridder D, Sandoval J, Vuilleumier N, Stringhini S, Spechbach H, Joost S, Kaiser L, Guessous I. Geospatial digital monitoring of COVID-19 cases at high spatiotemporal resolution. Lancet Digit Health. 2020 08; 2(8):e393-e394. PMID: 33328043.
      Citations: 4     Translation:Humans
    27. Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, De Ridder D, Petrovic D, Schrempft S, Marcus K, Yerly S, Arm Vernez I, Keiser O, Hurst S, Posfay-Barbe KM, Trono D, Pittet D, Gétaz L, Chappuis F, Eckerle I, Vuilleumier N, Meyer B, Flahault A, Kaiser L, Guessous I. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020 08 01; 396(10247):313-319. PMID: 32534626.
      Citations: 337     Fields:    Translation:HumansCellsPHPublic Health
    Guessous's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (319)
    Explore
    _
    Co-Authors (170)
    Explore
    _
    Similar People (60)
    Explore
    _